BLADURIL

This brand name is authorized in Ecuador, Mexico, South Africa

Active ingredients

The drug BLADURIL contains one active pharmaceutical ingredient (API):

1 Flavoxate UNII 9C05J6089W - FLAVOXATE HYDROCHLORIDE

Flavoxate is an antispasmodic selective to the urinary tract. Flavoxate has been shown to have a direct antispasmodic action on smooth muscle fibres. Read about Flavoxate

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BLADURIL Film-coated tablet	Health Products Regulatory Authority (ZA)	MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G04BD02	Flavoxate	G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BD Urinary antispasmodics
Discover more medicines within G04BD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 24.609-07-02
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 248M89
Country: ZA	Health Products Regulatory Authority	Identifier(s): 56/18/0136